DNA
Your biological blueprint
Helps identify genetic variants and patterns that may contribute to dysfunction.

Your biology is unique.
Your therapy should be too.
Why did YOUR biology respond this way when someone else's didn't?
That answer goes far deeper than an exposure, a diagnosis, MTHFR—or a handful of SNPs.
Neo7 looks for the WHY.


Don't lead with another Lyme test, mold test, viral test, COVID antibody test or cancer test. Those may tell you what is present or what you've been diagnosed with. We want to understand WHY your biology is responding the way it is.
But it doesn't tell us why your biology is behaving the way it is.
Neo7 looks across multiple layers of biological data to identify patterns of abnormal signaling, immune dysfunction, cellular stress and disrupted communication between systems.
It's not simply about an exposure, mutation or diagnosis. It's about finding the biological WHY behind it.
We Look at How the Pieces Work Together.
Most laboratory testing provides valuable information about individual parts of your health. Neo7 goes deeper by assessing an enormous scale of molecular values, relationships, and potential combinations across your biology to develop a complete picture of what is happening inside the body.

Your biological blueprint
Helps identify genetic variants and patterns that may contribute to dysfunction.
Real-time insight into cancer biology
Provides information about tumor-associated material circulating in the blood, including molecular changes that may help characterize disease activity.
What your genes are doing right now
Provides a snapshot of gene expression and signaling activity occurring in real time.
What your body is producing
Provides another functional layer of information about protein activity and biological processes.
How your immune system recognizes and presents signals
Important for designing personalized peptides that appropriately interact with the individual's immune biology.
“Finally, someone is looking deeper than my diagnosis.”
We don't simply collect more data. We look for the molecular patterns connecting it to design therapies built for you.
From Biological Data To A Personalized Strategy
Biological samples are collected to provide the molecular data needed for analysis.
Neo7 evaluates multiple layers of biological information to identify abnormal signaling, pathway dysfunction and molecular patterns.
Our technology and scientific team identify personalized molecular targets based on the patient's findings.
Peptide sequences are designed around those selected targets and the individual's biology.
The patient's licensed healthcare provider determines how Neo7 fits into the overall care strategy and oversees implementation.
Follow-up testing can evaluate how targeted biological signals have changed over time and help inform the next phase of the patient's personalized strategy.
Neo7's PBIMA® — Precision Based Immuno-Molecular Augmentation — technology integrates advanced molecular analysis with human scientific expertise to identify personalized biological targets.
Instead of simply targeting the most abnormal individual marker, Neo7 looks for patterns across interconnected biological pathways to identify signals that may be influencing broader areas of dysfunction.
Those findings guide the design of a personalized peptide solution created specifically for the individual.
Your data. Your targets. Your peptide design.
Explore The Science

The Diagnosis May Be the Same. The Biology Is Not.
Two patients can have the same cancer type and stage—yet have different mutations, immune responses, signaling pathways, and treatment outcomes. Using blood, urine, and tumor tissue when available, Neo7 evaluates the patient’s current cancer biology to explore how the disease may be communicating, adapting, and avoiding immune recognition.
Those findings guide a personalized, multi-target peptide strategy designed specifically for that patient—and able to work alongside conventional oncology and integrative care.
Designed for patients navigating: A New Diagnosis · Active Treatment · Advanced or Metastatic Disease · Recurrence or Progression · Remission and Continued Molecular Monitoring
EXPLORE CANCER
When the Diagnosis Does Not Explain the Whole Story, Where Do You Look Next?
Autoimmune, neurological, cardiovascular, congenital, chronic, and unexplained conditions can affect several biological systems at once.
Neo7 looks beyond the diagnosis—or the absence of one—to evaluate active gene signaling, immune communication, cellular stress, and protein patterns that may be connected to the patient’s symptoms and loss of function.
Those findings guide a personalized, multi-target peptide strategy based on the patient’s biology today.
Designed for patients navigating: Autoimmune Disease · Neurological & Neuroimmune Conditions · Cardiovascular Disease · Congenital Disorders · Chronic and Post-Viral Illness · Lyme and Environmental Illness · Complex or Unexplained Symptoms
EXPLORE ACTIVE DISEASE
Still Not Feeling Like Yourself After COVID or mRNA Exposure?
Persistent symptoms following viral illness or mRNA exposure can look very different from one person to another.
SPIKEX evaluates biological signals associated with viral and mRNA exposure, including changes involving RNA activity, protein function and immune regulation.
The goal is to identify which biological pathways appear disrupted in you and use those findings to guide a personalized strategy.
EXPLORE SPIKEX
What Is Your Biology Telling You About How You're Aging?
Age alone doesn't tell the whole story.
Neo7 Resilience evaluates interconnected biological pathways associated with cellular aging, inflammation, mitochondrial function, immune regulation, metabolism, DNA repair, stress, recovery and overall function.
Those findings provide a deeper picture of biological resilience and guide a personalized strategy designed around the individual.
EXPLORE RESILIENCENeo7 evaluates multiple layers of biology to better understand how molecular systems and pathways may be interacting.
Your DNA provides the blueprint. RNA and protein activity provide additional insight into what your biology is doing now.
Neo7 does not select peptides simply because someone has a particular diagnosis. Personalized targets are identified from the individual's molecular findings.
The information identified through Neo7's analysis is used to develop peptide sequences specifically designed around the patient's selected molecular targets.
Neo7 is designed to complement physician-directed conventional, functional and integrative care—not replace it.
Whether you are a patient seeking molecular clarity or a healthcare provider delivering targeted solutions, Neo7 empowers your journey with multi-omic intelligence.
FOR PATIENTS
Neo7 gives you and your healthcare provider another way to look at the problem—through your own molecular biology.
Wondering if Neo7 is right for you? Join a Neo7 Patient Discovery Call to learn how the process works, explore the different programs and ask questions directly.
FOR PROVIDERS
Neo7 gives healthcare providers access to advanced multi-omic analysis and personalized peptide design that can be incorporated into an individualized patient-care strategy.
Neo7 is not intended to replace the care you're already providing. It gives you another layer of molecular intelligence to help personalize it.
Whether you're treating complex disease, cancer, chronic illness, post-viral conditions or patients focused on healthy aging, Neo7 can help you better understand the biology of the individual sitting in front of you.
Interested in bringing Neo7 into your practice?
Already a Neo7 Provider? ACCESS THE PROVIDER PORTAL →
Neo7 looks across multiple layers of biological data to identify patterns of abnormal signaling, immune dysfunction, cellular stress and disrupted communication between systems.



Your diagnosis may tell us the name of the disease.
Your biology can tell us much more.
Discover what a precision molecular approach could reveal about you—or your patients.
This is advanced medicine built around the individual.